Greg Zante, Chief Financial Officer at Viking Therapeutics, Inc. (VKTX), sold 97,839 shares at $18.00 ($1.8M) on 2023-04-12, disclosed to the SEC on 2023-04-13.
Open-market sale of $1.8M VKTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 56,295 | $1.0M | 57.5% |
| 2 | $18.00 | 41,544 | $748K | 42.5% |
| Total | $18.00 avg | 97,839 | $1.8M | 100% |
| Filing → |
| VKTX | SELL | 2025-10-28 | $216K | — | Filing → |
| VKTX | SELL | 2025-07-03 | $237K | — | Filing → |
| VKTX | SELL | 2025-01-06 | $4.1M | — | Filing → |